Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 25, 16:01
1009.60
6.55 (0.65%)
VOLUME 2,574
LIVE
NSE
Apr 25, 16:01
1007.15
1 (0.1%)
VOLUME 15,272
Download Annual Report PDF Format 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Quarterly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Dec '16 Sep '16 Jun '16 Mar '16 Dec '15
Net Sales/Income from operations 141.12 136.14 138.09 133.51 144.56
Other Operating Income 9.16 2.02 1.45 25.31 0.02
Total Income From Operations 150.29 138.17 139.54 158.82 144.58
EXPENDITURE
Consumption of Raw Materials 2.44 3.06 3.20 8.69 5.06
Purchase of Traded Goods 35.67 27.62 50.78 48.21 46.29
Increase/Decrease in Stocks 8.93 13.49 -9.23 -5.21 2.72
Power & Fuel -- -- -- -- --
Employees Cost 38.12 46.96 42.33 50.86 38.81
Depreciation 4.02 4.06 4.07 4.24 4.44
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 50.18 43.82 36.50 53.07 40.06
P/L Before Other Inc. , Int., Excpt. Items & Tax 10.92 -0.84 11.90 -1.03 7.19
Other Income 9.83 1.82 1.56 2.09 1.48
P/L Before Int., Excpt. Items & Tax 20.75 0.98 13.46 1.06 8.67
Interest -- -- -- -- --
P/L Before Exceptional Items & Tax 20.75 0.98 13.46 1.06 8.67
Exceptional Items -- -- -- -- --
P/L Before Tax 20.75 0.98 13.46 1.06 8.67
Tax 4.79 0.19 2.90 0.50 --
P/L After Tax from Ordinary Activities 15.96 0.79 10.57 0.56 8.67
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 15.96 0.79 10.57 0.56 8.67
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 6.39 0.31 4.23 0.22 3.47
Diluted EPS 6.39 0.31 4.23 0.22 3.47
EPS After Extra Ordinary
Basic EPS 6.39 0.31 4.23 0.22 3.47
Diluted EPS 6.39 0.31 4.23 0.22 3.47
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of AstraZeneca

  • News
  • Results
  • Estimates
  • Analysis
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.